Effects of terlipressin on systolic pulmonary artery pressure of patients with liver cirrhosis: An echocardiographic assessment

World Journal of Gastroenterology

Volumn 10, Issue 15, 2004, Pages 2278-2280

  Altintas, Engin ^a   Akkus, Necdet ^a   Gen, Ramazan ^a   Helvaci, M Rami ^a   Sezgin, Orhan ^a   Oguz, Dilek ^b  

^a MERSIN UNIVERSITY   (Turkey)

^b TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

TERLIPRESSIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; ECHOCARDIOGRAPHY; FEMALE; HUMAN; LIVER CIRRHOSIS; LUNG ARTERY PRESSURE; MALE; PULMONARY HYPERTENSION; REST; SITTING; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 4344610025     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i15.2278     Document Type: Article

References (17)

1. Hervé P, Lebrec D, Brenot F, Simonneau G, Humbert M, Sitbon O, Duroux P. Pulmonary vascular disorders in portal hypertension. Eur Respir J 1998; 11: 1153-1166
2. Krowka MJ. Hepatopulmonary syndrome and portopulmonary Hypertension. Curr Treat Options Cardiovasc Med 2002; 4: 267-273
3. Budhiraja R, Hassoun PM. Portopulmonary hypertension; A tale of two circulations. Chest 2003; 123: 562-576
4. Naeije R. Hepatopulmonary syndrome and portopulmonary hypertension. Swiss Med Wkly 2003 Mar 22; 133: 163-169
5. Kuo PC, Johnson LB, Plotkin JS, Howell CD, Bartlett ST, Rubin LJ. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. Transplantation 1997; 63: 604-606
6. Rafanan AL, Maurer J, Mehta AC, Schilz R. Progressive portopulmonary hypertension after liver transplantation treated with epoprostenol. Chest 2000; 118: 1497-1500
7. Schroeder RA, Rafii AA, Plotkin JS, Johnson LB, Rustgi VK, Kuo PC. Use of aerosolized inhaled epoprostenol in the treatment of portopulmonary hypertension. Transplantation 2000; 70: 548-550
8. Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000; 6: 443-450
9. Krowka MJ, Tajik AJ, Dickson ER, Wiesner RH, Cortese DA. Intrapulmonary vascular dilatations in liver transplant candidates: screening by two-dimensional contrast enhanced echocardiography. Chest 1990; 97: 1165-1170
10. Lange PA, Stoller JK. The hepatopulmonary syndrome. Ann Intern Med 1995; 22: 521-529
11. Torregrosa M, Genesca J, Gonzalez A, Evangelista A, Mora A, Margarit C, Esteban R, Guardia J. Role of Doppler echocardiography in the assessment of portopulmonary hypertension in liver transplantation candidates. Transplantation 2001; 71: 572-574
12. Findlay JY, Harrison BA, Plevak DJ, Krowka MJ. Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension. Liver Transpl Surg 1999; 5: 381-387
13. Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000; 6: 443-450
14. Pirenne J, Verleden G, Nevens F, Delcroix M, Van Raemdonck D, Meyns B, Herijgers P, Daenen W, De Leyn P, Aerts R, Coosemans W, Decaluwe H, Koek G, Vanhaecke J, Schetz M, Verhaegen M, Cicalese L, Benedetti E. Combined liver and (heart-) lung transplantation in liver transplant candidates with refractory portopulmonary hypertension. Transplantation 2002; 73: 140-142
15. Oberti F, Veal N, Kaassis M, Pilette C, Rifflet H, Trouve R, Cales P. Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats. J Hepatol 1998; 29: 103-111
16. Moller S, Hansen EF, Becker U, Brinch K, Henriksen JH, Bendtsen F. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients. Liver 2000; 20: 51-59
17. Escorsell A, Bandi JC, Moitinho E, Feu F, Garcia-Pagan JC, Bosch J, Rodes J. Time profile of the haemodynamic effects of terlipressin in portal hypertension. J Hepatol 1997; 26: 621-627